Search Results - "Myers, Amanda A."

Urinary Outcomes After Magnetic Resonance Imaging-Guided Whole-Gland Transurethral Ultrasound Ablation for Prostate Cancer: Comparison of Suprapubic Tube to Indwelling Urethral Catheter by Rabinowitz, Matthew J, Haney, Nora M, Myers, Amanda A, Dora, Chandler D, Pavlovich, Christian P

“…MRI-guided transurethral ultrasound ablation (TULSA) is under investigation for whole-gland ablation of low- and intermediate-risk prostate cancer. The ideal…”
Get more information

Toward standardization in bladder cancer clinical trials: Guidance from the SITC-IBCG expert panel by Myers, Amanda A, Kamat, Ashish M, Kilbert, Angela, Galsky, Matthew D

“…Abstract…”
Get full text

Independent external validation of a nomogram to define risk categories for a significant decline in estimated glomerular filtration rate after robotic‐assisted partial nephrectomy by Bajalia, Essa M, Myers, Amanda A, Haehn, Daniela A, Kahn, Amanda E, Ball, Colleen T, Thiel, David D

“…Objective To validate the Martini nomogram predicting the decline in estimated glomerular filtration rate after robotic‐assisted partial nephrectomy. Methods…”
Get full text

Reply to Christopher Guske, Seyed Behzad Jazayeri, and Roger Li’s Letter to the Editor re: Amanda A. Myers, Wei Shen Tan, Valentina Grajales, et al. Challenging the Paradigm of “BCG-unresponsive” Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.05.027 by Myers, Amanda A., Kamat, Ashish M.

Get full text

‘Case of the Month’ from The University of Texas MD Anderson Cancer Center, Houston, Texas, USA: ependymoma of the urinary bladder by Myers, Amanda A., Tan, Wei Shen, Groot, John, Westney, Ouida Lenaine, Kamat, Ashish M.

Get full text

The evolving role of multidisciplinary teams in optimizing non-muscle invasive bladder cancer care by Myers, Amanda A., Steinmetz, Alexis R., Kamat, Ashish M.

Get full text

Challenging the Paradigm of “BCG-unresponsive” Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect? by Myers, Amanda A., Tan, Wei Shen, Grajales, Valentina, Hwang, Hyunsoo, Bree, Kelly K., Navai, Neema, Lee, Byron H., Dinney, Colin P.N., Kamat, Ashish M.

Get full text

Novel laser therapies and new technologies in the endoscopic management of upper tract urothelial carcinoma: a narrative review by Myers, Amanda A, Pak, Raymond W

“…Upper tract urothelial carcinoma (UTUC) is a rare disease. The gold standard treatment is radical nephroureterectomy (RNU). Endoscopic management of UTUC has…”
Get full text

Evaluation of Peri-operative Outcomes Associated With Resident Involvement on Tumor Resection and Renorrhaphy During Robotic-assisted Partial Nephrectomy by Myers, Amanda A., Geldmaker, Laura E., Haehn, Daniela A., Bajalia, Essa M., Ball, Colleen T., Thiel, David D.

“…To evaluate perioperative outcomes of resident trainee involvement in tumor resection and renorrhaphy during robotic assisted partial nephrectomy (RAPN). We…”
Get full text

Evaluation of Routine Postoperative Labs Following Robotic Assisted Partial Nephrectomy in Patients With Normal Preoperative Renal Function by Myers, Amanda A., Geldmaker, Laura E., Haehn, Daniela A., Ball, Colleen T., Thiel, David D.

“…To evaluate predictors of abnormal routine postoperative day 1 (POD1) labs in patients with normal pre-operative renal function following robotic assisted…”
Get full text

Analysis of Holmium Laser Enucleation of Prostate Fixed Operating Room Times by Myers, Amanda A., Geldmaker, Laura E., Hasse, Christopher H., Houghton, Patrick A., Haehn, Daniela A., Anyane-Yeboah, Abena N., Wieczorek, Mikolaj A., Ball, Colleen T., Dora, Chandler D., Thiel, David D.

“…OBJECTIVETo evaluate factors influencing fixed operating room time during holmium laser enucleation of the prostate. MATERIALS AND METHODSA prospective…”
Get full text

Novel plasma glycoprotein biomarkers predict progression-free survival in surgically resected clear cell renal cell carcinoma by Serie, Daniel J., Myers, Amanda A., Haehn, Daniela A., Parker, Alexander S., Bajalia, Essa M., Gonzalez, Giovanni A., Li, Qiongyu, Wong, Maurice Yu, Moser, Kaitlynn C., Zhou, Bo, Thiel, David D.

“…•High-throughput glycoproteomics evaluated differential expression of glycoprotein-isoforms as novel biomarkers.•Glycoprotein isoform differences were measured…”
Get full text

Complex Urethral Diverticulectomy: Is a Synchronous Prophylactic Autologous Fascial Sling Needed? by Schaaf, Amanda L, Lee, Yeonsoo S, Myers, Amanda A, Schommer, Jared, Gonzalez, Giovanni, Chen, Anita, Petrou, Steven

“…Urethral diverticulectomy is performed with or without concomitant pubovaginal sling (PVS). Patients with complex UD are more frequently offered concomitant…”
Get more information

Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023? by Myers, Amanda A, Briganti, Alberto, Leibovich, Bradley, Lerner, Seth P, Moschini, Marco, Rouprêt, Morgan, Shariat, Shahrokh F, Spiess, Philippe E, Stenzl, Arnulf, Taneja, Samir S, Touijer, Karim A, Kamat, Ashish M

“…Lymphadenectomy during surgery for genitourinary malignancies has varying benefits. To review contemporary evidence on lymph node dissection in genitourinary…”
Get full text

Analysis of fixed and variable operating room (or) time point efficiency in partial nephrectomies: open versus robotic-assisted by Geldmaker, Laura E., Hasse, Christopher H., Baird, Bryce A., Ericson, Christian A., Myers, Amanda A., Haehn, Daniela A., Anyane-Yeboah, Abena N., Wieczorek, Mikolaj A., Ball, Colleen T., Lyon, Timothy D., Pak, Raymond W., Thiel, David D.

“…To analyze operating room (OR) efficiency by evaluating fixed and variable OR times for open (OPN) and robotic-assisted partial nephrectomies (RAPN). We…”
Get full text

MP70-16 FEMALES WITH BLADDER CANCER ARE UNDERREPRESENTED IN CLINICAL TRIALS IN THE UNITED STATES by Myers, Amanda A., Steinmetz, Alexis R., Grajales, Valentina, Bree, Kelly K., Duan, Zhigang, Makaraoff, Lydia, Kamat, Ashish M.

Get full text

PD30-08 ELUCIDATING THE RESPONSE RATES TO CONTINUED BACILLUS CALMETTE-GUERIN (BCG) IN PATIENTS WITH BCG EXPOSED BLADDER CANCER: IMPLICATIONS FOR CLINICAL TRIAL DESIGN by Myers, Amanda A., Tan, Wei Shen, Grajales, Valentina, Hwang, Hyunsoo, Bree, Kelly K., Navai, Neema, Lee, Byron H., Dinney, Colin P. N., Kamat, Ashish M.

Get full text

MP53-09 IMPACT OF SYSTEMIC THERAPY IN CLINICAL T1 SMALL-CELL NEUROENDOCRINE CARCINOMA OF THE BLADDER by Myers, Amanda A., Fang, Andrew M., Moussa, Mohammad Jad, Wilson, Nathaniel, Campbell, Matthew T., Guo, Charles C., Zhang, Miao, Siefker-Radtke, Arlene, Kamat, Ashish M., Alhalabi, Omar

Get full text

MP16-08 CHALLENGING THE PARADIGM OF “BCG UNRESPONSIVE” BLADDER CANCER: DOES ADDITIONAL BCG HAVE AN EFFECT? by Myers, Amanda A., Tan, Wei Shen, Grajales, Valentina, Hwang, Hyunsoo, Bree, Kelly K., Navai, Neema, Lee, Byron H., Dinney, Colin P. N., Kamat, Ashish M.

Get full text